what are the main glp 1 drugs Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Drug Comparison in Diabetes
Description
Less but better has been an industry mantra for years
The non-inferiority design requires a smaller study participant sample and a shorter observation period
At the time of diagnosis of clinical ASCVD in a patient with T2D on a drug regimen that does not include a GLP-1 RA or an SGLT-2 inhibitor with demonstrated cardiovascular benefit
Less frequent dosing may outweigh the discomfort of a little jab
Based on these findings, PIONEER 6 supports preliminary cardiovascular safety for the treatment of T2DM
Stay tuned for part 3 of this series where I will discuss the benefits of using these medications
